Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate.
Survivors usually have low quality of life. Current clinical management strategies are …

The outbreak of COVID-19 in December 2019, has become an urgent and serious public
health emergency. At present, there is no effective treatment or vaccine for COVID-19 …

Sulfur mustard (SM) is a highly toxic chemical warfare agent that causes acute lung injury
(ALI) and/or acute respiratory distress syndrome (ARDS). There are no effective therapeutic …

Introduction Mesenchymal stromal cell (MSC)-based therapy has generated great hope for
the treatment of various diseases such as myocardial infarction and stroke. Unfortunately …

Abstract The coronavirus disease 2019 (COVID-19) has been threatening the globe since
the end of November 2019. The disease revealed cracks in the health care system as health …

The effectiveness of mesenchymal stem cells (MSCs) on inflammation-related disease is
limited and the pharmaceutical preparation that was used to enhance the efficacy of MSCs …

Ex vivo lung perfusion (EVLP) is an excellent platform to apply novel therapeutics, such as
gene and cell therapies, before lung transplantation. We investigated the concept of human …

Pulmonary fibrosis (PF) is the end stage of severe lung diseases, in which the lung
parenchyma is replaced by fibrous scar tissue. The result is a remarkable reduction in …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to
coronavirus disease 2019 (COVID-19). Virus-specific immunity controls infection …

Articular cartilage injury is common in various conditions, including osteoarthritis, rheumatic
diseases, and trauma. Current treatments for cartilage injury fail to completely regenerate …